SCHEMBL261502

SCHEMBL261502

CC#CC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butane SCHEMBL8950794 0.87
SCHEMBL20299959 0.78 APLNR (0.60)
SCHEMBL20299957 0.76 APLNR (0.57)
SCHEMBL13431158 0.72 APLNR (0.56)
SCHEMBL12772761 0.72
SCHEMBL821860 0.71
SCHEMBL23858500 0.67
SCHEMBL9860569 0.65
SCHEMBL15912583 0.65
SCHEMBL9860573 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 EP claimed
CN-112638910-B New heterocyclic amine derivatives and pharmaceutical compositions containing the same 株式会社大熊制药 2024-06-11 CN claimed
US-20240109896-A1 FGFR KINASE INHIBITOR AND USE THEREOF YA THERAPEUTICS INC (CN) 2024-04-04 US claimed
EP-3478687-B1 PYRAZOLOPYRIMIDINE DERIVATIVES AS KINASE INHIBITOR DAEWOONG PHARMACEUTICAL CO LTD (KR) 2024-03-20 EP claimed
WO-2023226580-A1 PYRROLOPYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF 中国医学科学院药物研究所 2023-11-30 WO claimed
EP-4006035-B1 QUINAZOLINE DERIVATIVES AS TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER NEUPHARMA INC (US) 2023-11-22 EP claimed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 WO claimed
EP-3481831-B1 4-AMINOPYRAZOLO[3,4-D]PYRIMIDINYLAZABICYCLO DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAEWOONG PHARMACEUTICAL CO LTD (KR) 2023-09-06 EP claimed
CN-116283534-A Multifunctional chiral eneyne ligand and preparation method and application thereof 中国石油化工股份有限公司 2023-06-23 CN claimed
CN-111057021-B S-triazine compound, preparation method and application thereof 中国药科大学 2023-05-23 CN claimed
US-20040085022-A1 Gas discharge panel and production method thereof FUJITSU HITACHI PLASMA DISPLAY LIMITED (JP) 2004-05-06 US claimed
EP-1416510-A2 Gas discharge panel and production method thereof Fujitsu Hitachi Plasma Display Limited (JP) 2004-05-06 EP claimed
EP-1165547-B1 SUBSTITUTED BENZOYLPYRAZOLES AS HERBICIDES BAYER CROPSCIENCE AG (DE) 2003-08-27 EP claimed
US-6608004-B2 Nitrogen compounds such as 2-(5-(N-phenoxy-carbonyl-N-ethyl-sulphonylamino)-4-cyano-2-fluoro-phenyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione, used as postemergence herbicides BAYER AKTIENGESELLSCHAFT (DE) 2003-08-19 US claimed
EP-0788511-B1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO (JP) 2002-12-11 EP claimed
US-5175166-A Cognition activators THE UNIVERSITY OF TOLEDO (US) 1992-12-29 US claimed
WO-1992021682-A1 PROCESSES FOR THE PREPARATION OF CEPHALOSPORINS AND OF PHARMACEUTICAL COMPOSITION CONTAINING THEM BEECHAM GROUP P.L.C. (GB) 1992-12-10 WO claimed
EP-0504216-A1 CEPHALOSPORINS, PROCESSES FOR THEIR PREPARATION, INTERMEDIATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Beecham Group p.l.c. (GB) 1992-09-23 EP claimed
WO-1991009038-A1 CEPHALOSPORINS, PROCESSES FOR THEIR PREPARATION, INTERMEDIATES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BEECHAM GROUP PLC (GB) 1991-06-27 WO claimed
EP-0191542-B1 ARYLCYCLOBUTYLALKYL AMINES AND THEIR USE AS ANTIDEPRESSIVE MEDICINES The Boots Company PLC (GB) 1988-06-08 EP claimed